Douglas Melton

HSCI scientists advance Type 1 diabetes therapy by protecting cells from immune attack and stress The stem cell-based approach to treating Type 1 diabetes (T1D) is successfully being tested in the clinic, using a transplant of stem cell-derived beta cells...

Douglas Melton, Co-Director of the Harvard Stem Cell Institute (HSCI), has received a financial grant from His Highness Sheikh Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi. The grant will bolster HSCI research focusing on accelerating gene...

Promising early results show that longstanding Harvard Stem Cell Institute (HSCI) research may have paved the way for a breakthrough treatment of Type 1 diabetes. Utilizing research from the Melton Lab, Vertex Pharmaceuticals has developed VX-880, an...

The JDRF Center of Excellence in New England will accelerate beta cell replacement therapy Harvard Stem Cell Institute (HSCI) co-director Douglas Melton, Ph.D., will lead a new multi-institutional center funded by JDRF to advance type 1 diabetes research...

HSCI scientists have combined organ-on-a-chip and stem-cell technologies to make a powerful tool for diabetes research and beta-cell transplantation By Mary Todd Bergman By combining two powerful technologies, scientists are taking diabetes research to a...

Harvard-led research boosts the yield of insulin-producing cells for diabetes therapy By Jessica Lau Summary Harvard University researchers used single-cell sequencing to identify a protein expressed uniquely by insulin-producing beta cells created from...

The Harvard Stem Cell Institute (HSCI) was launched in 2004 with the express goal of pursuing the promise of stem cell science. In April 2019 we celebrate our 15th anniversary, and reflect on how far we have come. Collaboration across Harvard Our founding...

Douglas Melton assumed his role as president of the International Society for Stem Cell Research (ISSCR) at the closing plenary of the society’s 2018 annual meeting. He steps into this role after two years on the executive committee and will serve in this...